v3.26.1
Stockholders' Equity
3 Months Ended
Mar. 27, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Equity Awards

The following table reflects the activity of RSAs and RSUs during the thirteen weeks ended March 27, 2026:
Time-BasedPerformance-BasedMarket-Based
SharesWeighted Average
Grant Date Fair Value
SharesWeighted Average
Grant Date Fair Value
SharesWeighted Average
Grant Date Fair Value
Unvested at December 26, 2025470,866 $48.71 1,307,313 $51.22 175,786 $37.10 
Granted200,793 72.73 190,035 72.43 33,535 72.43 
Vested(171,971)43.95 (119,145)32.55 (86,329)28.84 
Forfeited(13,925)48.84 (139,866)32.55 — — 
Unvested at March 27, 2026485,763 $60.32 1,238,337 $58.38 122,992 $52.53 

The Company granted 424,363 RSAs and RSUs to its employees and directors at a weighted average grant date fair value of $72.57 during the thirteen weeks ended March 27, 2026. These awards are a mix of time-, market- and performance-based grants that generally vest over a range of periods up to five years. The Company recognized expense on its RSAs and RSUs totaling $4,139 and $4,121 during the thirteen weeks ended March 27, 2026 and March 28, 2025, respectively. No share-based compensation expense has been capitalized.

At March 27, 2026, the total unrecognized compensation cost for unvested RSAs and RSUs was $42,319 and the weighted-average remaining period was approximately 2.1 years. Of this total, $27,097 related to awards with time-based vesting provisions and $15,222 related to awards with performance- and market-based vesting provisions. At March 27, 2026, the weighted-average remaining period for time-based vesting and performance-based vesting RSAs and RSUs were approximately 1.9 years and 2.4 years, respectively.

Share Repurchase Program

In November 2023, the Company announced a two-year share repurchase program in an amount up to $100,000. In February 2026, the board of directors authorized the extension of the share repurchase program for ten years, subject to that same $100,000 limit. The remaining share purchase authorization was $57,617 at March 27, 2026. The Company is not obligated to repurchase any specific number of shares and may suspend or discontinue the program at any time.